Erythropoietic Porphyria Therapeutics Market: Clinical Innovation, Pipeline Dynamics, and Future Growth Outlook

https://researchintelo.com/rep....ort/erythropoietic-p

The erythropoietic porphyria therapeutics market was valued at $850 million in 2025 and is projected to reach $2.74 billion by 2034, growing at 14.2% CAGR.